P3 Laboratory of Inner Mongolia Biwei Antai Biotechnology Co., Ltd.-Shanghai Jiehao Biotechnology

Shanghai Jiehao Biotechnology Co., Ltd. helps Biwei Antai to build a high standardP3Biosafety Laboratory

Project Background

Inner Mongolia Biwei Antai Biotechnology Co., Ltd., a focus on veterinary biological products research and development and production of enterprises, especially in the field of foot-and-mouth disease vaccine has significant research and development and production capacity. With the expansion of the company's business and the improvement of biosafety requirements, Biwei Antai and Shanghai Jiehao Biotechnology Co., Ltd. launched a cooperation, Jiehao Biowei Antai.P3Labs offers a range of high-grade biosafety laboratory equipment to enhance the safety and efficiency of its laboratories.

Shanghai Jiehao Biotechnology Co., Ltd. includes:

1.Bio-Airtight Door: The bio-gas-tight door provided by Shanghai Jiehao adopts advanced air-tight technology to ensure the complete isolation of the internal and external environment of the laboratory and prevent the spread of pathogens. These doors are designed to meet the strict standards of biosafety laboratories, providing additional security for laboratory personnel.

2.airtight transfer window: The delivery window is an important equipment for the safe delivery of items in the laboratory. The airtight transfer window provided by Shanghai Jiehao adopts special sealing technology to ensure that the airtight environment of the laboratory will not be damaged during the transfer of articles, and it also supports VHP disinfection to ensure the biosafety of the transferred articles.

3.aqueduct: The aqueduct is a device used to transfer items within or between laboratories. The aqueduct provided by Shanghai Jiehao is designed to be sterilized by liquid disinfection, and is suitable for the transfer of items in high-level biosafety laboratories.

Project Implementation

Shanghai Jiehao's engineering team worked closely with Biwei Antai to ensure the accurate installation and commissioning of all equipment. The team not only provides high-quality products, but also provides comprehensive technical support and training to ensure that the staff of Biwei Antai can operate these equipment proficiently.

Outcomes and Impacts

P3laboratory not only ensures the safety of laboratory personnel, but also contributes to the development and production of veterinary biological products more effectively. This cooperation marks the further development of Biwei Antai in the field of biosafety, and also demonstrates the expertise of Shanghai Jiehao Biotechnology Co., Ltd. in providing biosafety solutions. The cooperation between the two companies not only improves Biwei Antai's biosafety laboratory standards, but also sets a new benchmark for biosafety practices in the veterinary biologics industry. Through continuous technological innovation and equipment upgrades, Biwei Antai and Shanghai Jiehao Biotechnology Co., Ltd. have jointly made positive contributions to promoting the development of the biotechnology field.

Shanghai Jiehao Biotechnology Co., Ltd. will continue to provide advanced biosafety solutions, and cooperate with more scientific research institutions and biopharmaceutical companies to jointly promote the development of biosafety and make greater contributions to human and animal health. By choosing Shanghai Jiehao, you will receive professional technical support and customized solutions to jointly build a safe and efficient biosafety environment.

Inner Mongolia Biwei Antai Biotechnology Co., Ltd. is a focus on veterinary biological products, especially foot-and-mouth disease vaccine research and development and production of enterprises. The company was established in June 2008 with a registered capital of 0.125 billion RMB and is located in Hohhot and Helinger County, Inner Mongolia. Biwei Antai has an advanced cell suspension culture biotechnology production line with an annual production capacity of 2 billion ml of foot-and-mouth disease vaccine for pigs, cattle and sheep, showing its strong production capacity in the field of veterinary vaccines.

The company has strong strength in technology and research and development, has a team composed of doctors, masters and other highly educated talents, and has rich experience in veterinary vaccine research and development, production, marketing and business management. Biwei Antai is recognized as a multi-level R & D center and technology center, including municipal "intellectual property work pilot unit", autonomous region "specialized and special new small and medium-sized enterprises", "enterprise R & D center", "key leading enterprise unit", "enterprise technology center" and national "high-tech enterprise", these honors prove its leading position and technical strength in the industry.

in the veterinary vaccine market, foot-and-mouth disease vaccine is the highest market share of veterinary vaccine products, Biwei Antai as one of the eight domestic foot-and-mouth disease vaccine manufacturers, occupies an important position in the industry. With the policy to promote market-oriented procurement and breeding scale, Biwei Antai's market space is expected to further expand, its competitiveness and influence in the field of veterinary vaccines will continue to increase.

To sum up, Inner Mongolia Biwei Antai Biotechnology Co., Ltd. has a significant industry position and market influence in the field of veterinary biological products, especially in the research and development and production of foot-and-mouth disease vaccines. The website of Inner Mongolia Biwei Antai Biotechnology Co., Ltd. is [https://www.bvbio.com/]. Through this website, you can learn more about the company's detailed information and latest developments.